Ads
related to: acute leukemia prognosis bone marrow- Pediatric CML Patients
Learn About a Treatment Option
For Children with Ph+ CML in CP
- Ph+ CML Video
Watch a Video and Get More
Information on CML
- Dosing Information
Learn More Today
See Dosing & Administration Info.
- Sign Up For Support
Get Informative Support
Information. Sign Up Here
- Pediatric CML Patients
Search results
Results from the WOW.Com Content Network
The five-year survival rate is about 35% in people under 60 years old and 10% in people over 60 years old. [3] Older people whose health is too poor for intensive chemotherapy have a typical survival of five to ten months. [3]
Possible treatments for acute leukemia include chemotherapy, steroids, radiation therapy, intensive combined treatments (including bone marrow or stem cell transplants), targeted therapy, and/or growth factors.
Five-year survival rate is 65% in the United States. [4] In children under 15 in first-world countries, the five-year survival rate is greater than 60% or even 90%, depending on the type of leukemia. [13] In children with acute leukemia who are cancer-free after five years, the cancer is unlikely to return.
Acute leukemia or acute leukaemia is a family of serious medical conditions relating to an original diagnosis of leukemia. In most cases, these can be classified according to the lineage, myeloid or lymphoid, of the malignant cells that grow uncontrolled, but some are mixed and for those such an assignment is not possible.
Prognosis. Five-year survival rate: 23.7% [1] Acute monocytic leukemia ( AMoL, or AML-M5) [2] is a type of acute myeloid leukemia. In AML-M5 >80% of the leukemic cells are of monocytic lineage. [3] This cancer is characterized by a dominance of monocytes in the bone marrow.
Lymphomas, lymphocytic leukemias, and myeloma are from the lymphoid line, while acute and chronic myelogenous leukemia, myelodysplastic syndromes and myeloproliferative diseases are myeloid in origin.
Ad
related to: acute leukemia prognosis bone marrow